Francesca Morelli Selected Research

Infections

1/2019

HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesca Morelli Research Topics

Disease

6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2022 - 12/2017
2	Neutropenia 01/2022 - 12/2021
2	Disease Progression 12/2021 - 01/2021
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2021
1	Lymphoma (Lymphomas) 01/2021
1	Trisomy (Trisomies) 01/2020
1	Paraproteinemias (Monoclonal Gammopathy) 01/2020
1	Venous Thromboembolism 01/2019
1	Infections 01/2019
1	Residual Neoplasm 12/2017
1	Myoma 12/2013

Drug/Important Bio-Agent (IBA)

3	Chlorambucil (Leukeran)FDA Link 12/2022 - 12/2017
3	obinutuzumabIBA 12/2022 - 12/2017
3	ibrutinibIBA 12/2021 - 01/2019
2	venetoclaxIBA 01/2022 - 12/2019
1	palbociclibIBA 12/2021
1	Immunoglobulin G (IgG)IBA 01/2020
1	Immunoglobulin M (IgM)IBA 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	ParaproteinsIBA 01/2020
1	fibrin fragment D (D-dimer)IBA 01/2019
1	Rituximab (Mabthera)FDA Link 12/2017

Therapy/Procedure

3	Therapeutics 01/2022 - 12/2017
1	Drug Tapering 01/2022
1	Salvage Therapy 01/2021
1	Hysterectomy 12/2013